Studies have shown that dysfunction in FGFR3 or mutations of FGFR3 are highly associated with multiple cancers, such as multiple myeloma, bladder cancer [31], breast cancer [32], and colorectal cancer [33]. The gene discussed is FGFR3; the disease is breast carcinoma.